Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry

OBJECTIVE: Congenital adrenal hyperplasia (CAH) requires exogenous steroid replacement. Treatment is commonly monitored by measuring 17‐OH progesterone (17OHP) and androstenedione (D4). DESIGN: Retrospective cohort study using real‐world data to evaluate 17OHP and D4 in relation to hydrocortisone (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawrence, Neil, Bacila, Irina, Dawson, Jeremy, Bryce, Jillian, Ali, Salma R., van den Akker, Erica L. T., Bachega, Tânia A. S. S., Baronio, Federico, Birkebæk, Niels H., Bonfig, Walter, van der Grinten, Hedi C., Costa, Eduardo C., de Vries, Liat, Elsedfy, Heba, Güven, Ayla, Hannema, Sabine, Iotova, Violeta, van der Kamp, Hetty J., Clemente, María, Lichiardopol, Corina R., Milenkovic, Tatjana, Neumann, Uta, Nordenström, Ana, Poyrazoğlu, Şukran, Probst‐Scheidegger, Ursina, De Sanctis, Luisa, Tadokoro‐Cuccaro, Rieko, Thankamony, Ajay, Vieites, Ana, Yavaş, Zehra, Faisal Ahmed, Syed, Krone, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796837/
https://www.ncbi.nlm.nih.gov/pubmed/35781728
http://dx.doi.org/10.1111/cen.14796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796837/
https://www.ncbi.nlm.nih.gov/pubmed/35781728
http://dx.doi.org/10.1111/cen.14796

Ejemplares similares